Aromatase inhibitors and bisphosphonates can improve survival in postmenopausal early-stage breast cancer, and combining the two drug classes can help negate their individual adverse effects,...
WASHINGTON – Women with type 2 diabetes who take estrogen therapy showed lower total gray matter volume, with atrophy particularly evident in the hippocampus.
A new analysis of the Women’s Health...
There’s been a flurry of legislative activity on Capitol Hill and at state houses around the country aimed at improving access to contraception. But there are still deep divides on the best way to...
Medicare officials have added the human papillomavirus test to its list of covered services for cervical cancer screening.
In a national coverage <a...
The Obama administration is aiming to give employers with a religious objection an easier way to opt out of providing birth control under the Affordable Care Act, while also preserving no-cost access...
Radioactive iodine (RAI) therapy in thyroid cancer patients does not cause such patients to get breast cancer, suggests a retrospective study of female patients from Seoul National University...
The periconceptional use of some selective serotonin reuptake inhibitors (SSRIs) appears to have no impact on the development of birth defects, but some birth defects occur more frequently among...
Women have seen a 20% decrease in their out-of-pocket expenses for oral contraceptives and intrauterine devices since the implementation of the Affordable Care Act’s mandate to cover contraceptives...
Though acute coronary syndromes are the leading cause of death in U.S. women, an analysis of clinical trials showed that enrollment among women remained disproportionately low from 1994 to 2010,...
As more physicians and women consider immediate postpartum insertion of an intrauterine device as a way to prevent rapid repeat pregnancy, the next step is getting the procedure covered by Medicaid....
